Figura Suplementar 2 de Distribuição Diferencial do Inibidor DNA-PKcs Peposertib Sensibiliza Seletivamente Xenograxpects de Metástases Cerebrais de Melanoma Derivados de Pacientes à Radioterapia

Ji et al. (Qua,) estudaram essa questão.

www.synapsesocial.com/papers/68e5778bb6db6435875173ee — DOI: https://doi.org/10.1158/1535-7163.27102352.v1

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Supplementary Figure 2 from Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts· 2024
2. Supplementary Figure 2 from Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts· 2024
3. Supplementary Figure 2 from Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts· 2024
4. Supplementary Figure 1 from Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts· 2024
5. Supplementary Figure 1 from Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts· 2024